Cargando…
Peptide modified geniposidic acid targets bone and effectively promotes osteogenesis
BACKGROUND: Geniposidic acid (GPA), one of the active components of Eucommia ulmoides, promote bone formation and treat osteoporosis by activating farnesoid X receptor (FXR). However, GPA has low oral availability and lack of bone targeting in the treatment of bone related diseases. With the develop...
Autores principales: | Liu, Meijing, Zhu, Danqi, Jin, Fujun, Li, Shuang, Liu, Xiangning, Wang, Xiaogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Speaking Orthopaedic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579733/ https://www.ncbi.nlm.nih.gov/pubmed/36313979 http://dx.doi.org/10.1016/j.jot.2022.07.007 |
Ejemplares similares
-
Translational perspective on bone-derived cytokines in inter-organ communications
por: Jin, Fujun, et al.
Publicado: (2022) -
Effects of Fructus Psoraleae Extract on the Intestinal Absorption Kinetics of Geniposide and Geniposidic Acid in Rat
por: Huo, Yan, et al.
Publicado: (2014) -
Generation of functional oligopeptides that promote osteogenesis based on unsupervised deep learning of protein IDRs
por: Cai, Mingxiang, et al.
Publicado: (2022) -
miR-146a-5p targets Sirt1 to regulate bone mass
por: Zheng, Mingxia, et al.
Publicado: (2021) -
Anti-inflammatory action of geniposide promotes wound healing in diabetic rats
por: Chen, Xiao-yan, et al.
Publicado: (2022)